{"id":"or-metformin-hcl-alone","safety":{"commonSideEffects":[{"rate":"20–30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3–5","effect":"Metallic taste"},{"rate":"10–30","effect":"Vitamin B12 deficiency (with long-term use)"},{"rate":"<0.1","effect":"Lactic acidosis (rare, in renal impairment)"}]},"_chembl":{"chemblId":"CHEMBL1703","moleculeType":"Small molecule","molecularWeight":"165.63"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that primarily works by decreasing gluconeogenesis in the liver and enhancing peripheral glucose uptake and utilization. It does not stimulate insulin secretion, making it weight-neutral and useful across a broad range of glycemic control needs. The drug also has modest effects on lipid metabolism and may reduce cardiovascular risk.","oneSentence":"Metformin HCl reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in patients with type 2 diabetes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:33.501Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Prediabetes (off-label or prevention studies)"},{"name":"Polycystic ovary syndrome (PCOS) with insulin resistance"}]},"trialDetails":[{"nctId":"NCT06899061","phase":"PHASE1","title":"Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-25","conditions":"Advanced Solid Malignancies","enrollment":41},{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":"Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection","enrollment":112},{"nctId":"NCT07460336","phase":"NA","title":"Effects of Cofrogliptin on Beta-Cell Function in LADA Patients","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-03-15","conditions":"Latent Autoimmune Diabetes in Adults (LADA)","enrollment":84},{"nctId":"NCT02365597","phase":"PHASE2","title":"An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2015-04-22","conditions":"Urothelial Cancer","enrollment":239},{"nctId":"NCT03006172","phase":"PHASE1","title":"To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2016-12-13","conditions":"Breast Cancer, Solid Tumor","enrollment":200},{"nctId":"NCT07446400","phase":"PHASE1","title":"A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together","status":"NOT_YET_RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-03-20","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT03710343","phase":"PHASE2","title":"Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2023-11-14","conditions":"Cerebral Palsy","enrollment":3},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT03934021","phase":"","title":"Gut Microbiota in Acute Stroke Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-07-01","conditions":"Stroke, Stroke, Acute, Stroke, Ischemic","enrollment":120},{"nctId":"NCT07141342","phase":"NA","title":"Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Participate in a Weight Loss Program, Half Will Receive Bed Scales, and Participants Who Receive the Bed Scales Are Expected to Have Increased Weight Loss.","status":"RECRUITING","sponsor":"Jonathan Pearlman","startDate":"2026-02-16","conditions":"Disability Physical, Wheelchair, Obesity; Overweight","enrollment":92},{"nctId":"NCT07417306","phase":"PHASE3","title":"A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor","status":"NOT_YET_RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2026-03-27","conditions":"Type 2 Diabetes","enrollment":912},{"nctId":"NCT07415226","phase":"","title":"Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-05-01","conditions":"Type 1 Diabetes Mellitus","enrollment":500},{"nctId":"NCT05743387","phase":"NA","title":"Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-05-13","conditions":"Type 2 Diabetes Mellitus (T2D)","enrollment":252},{"nctId":"NCT07399470","phase":"PHASE1","title":"A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.","status":"ACTIVE_NOT_RECRUITING","sponsor":"LG Chem","startDate":"2026-01-09","conditions":"Healthy Volunteers, Fasting Conditions","enrollment":58},{"nctId":"NCT07395960","phase":"PHASE1, PHASE2","title":"The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-09-01","conditions":"Mild Cognitive Impairment, Overweight or Obesity, Elderly","enrollment":54},{"nctId":"NCT07396844","phase":"PHASE1","title":"The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"LG Chem","startDate":"2026-07-01","conditions":"Healthy, Fasting, Fed","enrollment":28},{"nctId":"NCT07120971","phase":"EARLY_PHASE1","title":"Metformin for Premature Infants With Bronchopulmonary Dysplasia","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2025-12-19","conditions":"Bronchopulmonary Dysplasia (BPD)","enrollment":40},{"nctId":"NCT05164263","phase":"PHASE4","title":"Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study","status":"RECRUITING","sponsor":"Getz Pharma","startDate":"2021-04-01","conditions":"Type II Diabetes Mellitus, Efficacy, Self, Safety Issues","enrollment":2000},{"nctId":"NCT02087826","phase":"NA","title":"Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2014-04","conditions":"Genetics, Metabolism, Type 2 Diabetes","enrollment":1017},{"nctId":"NCT07336914","phase":"NA","title":"Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Gestational Diabetes","enrollment":60},{"nctId":"NCT07333742","phase":"PHASE1","title":"A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal","status":"COMPLETED","sponsor":"LG Chem","startDate":"2025-09-29","conditions":"Fed Conditions, Healthy Volunteer","enrollment":50},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT04691960","phase":"PHASE2","title":"A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2016-08","conditions":"Glioblastoma","enrollment":18},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT05515978","phase":"EARLY_PHASE1","title":"Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-10-10","conditions":"Prostate Cancer","enrollment":100},{"nctId":"NCT06688123","phase":"PHASE2","title":"Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-01-08","conditions":"Type 2 Diabetes","enrollment":275},{"nctId":"NCT07241897","phase":"PHASE3","title":"DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2025-12-15","conditions":"Ischemic Stroke, Diabete Mellitus","enrollment":312},{"nctId":"NCT07098299","phase":"PHASE1","title":"Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies","status":"RECRUITING","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2025-09-18","conditions":"Advanced Solid Tumor","enrollment":60},{"nctId":"NCT01797523","phase":"PHASE2","title":"A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-10-07","conditions":"Endometrial Cancer","enrollment":62},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT07215156","phase":"NA","title":"Metformin Versus Chlorhexidine Gel as Adjuncts to Scaling and Root Planing in Stage II Grade B Periodontitis","status":"NOT_YET_RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2025-10-06","conditions":"Stage II, Grade B Periodontitis, Chronic Periodontitis","enrollment":60},{"nctId":"NCT07188740","phase":"PHASE1","title":"Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-30","conditions":"DNMT3A Gene Mutation","enrollment":30},{"nctId":"NCT02710448","phase":"PHASE2","title":"May Metformin be Used in Renal Failure?","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2012-06","conditions":"Renal Disorder Associated With Type II Diabetes Mellitus","enrollment":82},{"nctId":"NCT06920056","phase":"PHASE1","title":"A Study of BGM0504 in Overweight or Obese Participants","status":"COMPLETED","sponsor":"BrightGene Bio-Medical Technology Co., Ltd.","startDate":"2025-03-24","conditions":"Overweight or Obese","enrollment":28},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT05365451","phase":"EARLY_PHASE1","title":"Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters","status":"COMPLETED","sponsor":"Washington State University","startDate":"2022-04-11","conditions":"Interaction, Endogenous Biomarkers","enrollment":16},{"nctId":"NCT07088523","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-07-31","conditions":"Diabete Mellitus, Ischemic Cardiovascular Disease","enrollment":4205},{"nctId":"NCT05929495","phase":"PHASE2","title":"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2024-02-12","conditions":"Glioblastoma, IDH-wildtype, Metformin, Malignancies","enrollment":25},{"nctId":"NCT02879409","phase":"NA","title":"HbA1c Variability in Type II Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Cornell Medical College in Qatar","startDate":"2016-11","conditions":"Diabetes Mellitus Type 2","enrollment":150},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT06804187","phase":"","title":"Sweet Sensing in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"University of Nottingham","startDate":"2025-02-01","conditions":"Type 2 Diabetes, Prediabetes","enrollment":505},{"nctId":"NCT06679413","phase":"PHASE1","title":"A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants","status":"COMPLETED","sponsor":"UCB BIOSCIENCES, Inc.","startDate":"2024-12-04","conditions":"Healthy Study Participants","enrollment":22},{"nctId":"NCT03675893","phase":"PHASE2","title":"RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-12-24","conditions":"Endometrial Cancer, Ovarian Cancer","enrollment":180},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT04090580","phase":"PHASE3","title":"Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-10-27","conditions":"Type 2 Diabetes","enrollment":88},{"nctId":"NCT06335134","phase":"PHASE1","title":"A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin","status":"COMPLETED","sponsor":"Hangzhou Sciwind Biosciences Co., Ltd.","startDate":"2023-07-14","conditions":"Healthy Volunteers","enrollment":57},{"nctId":"NCT06942390","phase":"PHASE2","title":"Topical Metformin Versus Topical Ketotifen in Melasma Treatment","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-06-01","conditions":"Melasma","enrollment":60},{"nctId":"NCT06107153","phase":"PHASE3","title":"Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control","status":"COMPLETED","sponsor":"University of Basrah","startDate":"2023-11-01","conditions":"Type2diabetes","enrollment":243},{"nctId":"NCT04288778","phase":"PHASE4","title":"A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes","status":"COMPLETED","sponsor":"Johnson & Johnson Private Limited","startDate":"2020-11-25","conditions":"Diabetes Mellitus","enrollment":276},{"nctId":"NCT05998837","phase":"PHASE2, PHASE3","title":"GLUcose Transport and REnalPROtection in Chronic Kidney Disease","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy","startDate":"2021-04-13","conditions":"Chronic Kidney Disease, Diabetes Mellitus, Type 2, Hypertension","enrollment":34},{"nctId":"NCT06882291","phase":"NA","title":"Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-03-20","conditions":"Polycystic Ovary Syndrome","enrollment":72},{"nctId":"NCT04114136","phase":"PHASE2","title":"Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies","status":"RECRUITING","sponsor":"Dan Zandberg","startDate":"2020-09-14","conditions":"Melanoma, NSCLC, Hepatocellular Carcinoma","enrollment":72},{"nctId":"NCT02851095","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-08","conditions":"Healthy","enrollment":44},{"nctId":"NCT02865668","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-08","conditions":"Healthy","enrollment":44},{"nctId":"NCT02846506","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-08","conditions":"Healthy","enrollment":44},{"nctId":"NCT02512523","phase":"PHASE4","title":"Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2015-08-27","conditions":"Type 2 Diabetes Mellitus","enrollment":39},{"nctId":"NCT06781775","phase":"PHASE4","title":"GDM: Insulin with or Without Metformin?","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2024-12-12","conditions":"Gestational Diabetes","enrollment":130},{"nctId":"NCT06353061","phase":"PHASE2","title":"Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-04-15","conditions":"Cervical Cancer, Radiotherapy, Metformin","enrollment":51},{"nctId":"NCT06772857","phase":"EARLY_PHASE1","title":"Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-07-18","conditions":"Insulin Sensitivity/Resistance","enrollment":3},{"nctId":"NCT06713967","phase":"NA","title":"Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage","status":"NOT_YET_RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2025-02-02","conditions":"Polycystic Ovarian Syndrome (PCOS), Pregnancy Outcomes","enrollment":70},{"nctId":"NCT06675994","phase":"","title":"In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme","status":"NOT_YET_RECRUITING","sponsor":"LifeBridge Health","startDate":"2024-12-01","conditions":"Healthy, Hypercholesterolemia, Hypertension","enrollment":80},{"nctId":"NCT04899349","phase":"PHASE2","title":"Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-04-06","conditions":"Breast Cancer","enrollment":2},{"nctId":"NCT02647827","phase":"PHASE2","title":"Acupuncture or Metformin for Insulin Resistance in Women With PCOS","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2015-12","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Hyperandrogenism","enrollment":303},{"nctId":"NCT04017221","phase":"","title":"Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients with Type 2 Diabetes","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2018-10-01","conditions":"Diabetes Mellitus, Type 2, Urosepsis, Diabetic Ketoacidosis","enrollment":1249636},{"nctId":"NCT05854966","phase":"PHASE2","title":"CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2024-12","conditions":"Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma","enrollment":""},{"nctId":"NCT03800602","phase":"PHASE2","title":"Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-01-15","conditions":"Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Refractory Colorectal Carcinoma","enrollment":29},{"nctId":"NCT05694221","phase":"PHASE1","title":"Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin","status":"COMPLETED","sponsor":"Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.","startDate":"2023-03-20","conditions":"Healthy Volunteers","enrollment":34},{"nctId":"NCT06495931","phase":"PHASE1","title":"Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-07","conditions":"Type 2 Diabetes Mellitus","enrollment":24},{"nctId":"NCT03194945","phase":"PHASE4","title":"Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2017-11-01","conditions":"Type 2 Diabetes Mellitus","enrollment":412},{"nctId":"NCT03041129","phase":"","title":"Post-Prandial Liver Glucose Metabolism in PCOS","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2017-04-14","conditions":"Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis","enrollment":19},{"nctId":"NCT05182970","phase":"PHASE3","title":"Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2021-12-02","conditions":"PreDiabetes, Acute Myocardial Infarction, Non ST Elevation Myocardial Infarction","enrollment":5160},{"nctId":"NCT05702905","phase":"PHASE4","title":"Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2023-05-09","conditions":"PCOS (Polycystic Ovary Syndrome), Semaglutide","enrollment":75},{"nctId":"NCT04593459","phase":"PHASE4","title":"Probiotic Intervention in PCOS","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2020-11-03","conditions":"Polycystic Ovary Syndrome","enrollment":112},{"nctId":"NCT06218342","phase":"PHASE4","title":"Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2024-02-15","conditions":"Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease","enrollment":156},{"nctId":"NCT04684420","phase":"PHASE1","title":"GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) Study","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2020-12-22","conditions":"Healthy","enrollment":81},{"nctId":"NCT06164535","phase":"PHASE4","title":"The Effects of DPPIs on Cognitive Function of Diabetic Patients","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-12-30","conditions":"Cognitive Impairment","enrollment":105},{"nctId":"NCT05815680","phase":"PHASE1","title":"A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects","status":"COMPLETED","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","startDate":"2023-04-06","conditions":"Overweight Subjects, Obese Subjects","enrollment":48},{"nctId":"NCT06124495","phase":"PHASE1","title":"Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.","status":"COMPLETED","sponsor":"Galenicum Health","startDate":"2023-01-13","conditions":"Bioequivalence, Diabetes Mellitus, Type 2","enrollment":58},{"nctId":"NCT06124547","phase":"PHASE1","title":"Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.","status":"COMPLETED","sponsor":"Galenicum Health","startDate":"2023-01-16","conditions":"Bioequivalence, Diabetes Mellitus, Type 2","enrollment":48},{"nctId":"NCT02574845","phase":"PHASE1","title":"DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2015-10-12","conditions":"Healthy","enrollment":18},{"nctId":"NCT02231931","phase":"PHASE1","title":"Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-09-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT05526690","phase":"PHASE1","title":"Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-10-28","conditions":"Hypertension","enrollment":27},{"nctId":"NCT05981742","phase":"PHASE2","title":"Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS","status":"COMPLETED","sponsor":"Al-Rasheed University College","startDate":"2022-09-21","conditions":"Polycystic Ovary Syndrome","enrollment":75},{"nctId":"NCT05893849","phase":"","title":"Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-03-28","conditions":"Aging","enrollment":624},{"nctId":"NCT00139477","phase":"NA","title":"Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2003-11","conditions":"Obesity","enrollment":66},{"nctId":"NCT05463094","phase":"PHASE1","title":"GXR RM China BE Study (Darmstadt - Jiangsu)","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2022-07-25","conditions":"Healthy","enrollment":84},{"nctId":"NCT02659306","phase":"PHASE1","title":"Metformin Immunotherapy in HIV Infection","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2016-09","conditions":"HIV Infection","enrollment":22},{"nctId":"NCT04754334","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Oramed, Ltd.","startDate":"2021-03-16","conditions":"T2DM (Type 2 Diabetes Mellitus)","enrollment":346},{"nctId":"NCT03135301","phase":"PHASE3","title":"Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06-20","conditions":"Infertility, Female","enrollment":80},{"nctId":"NCT04634890","phase":"NA","title":"Bialystok Exercise Study in Diabetes","status":"UNKNOWN","sponsor":"Medical University of Bialystok","startDate":"2016-08-11","conditions":"Type 2 Diabetes, PreDiabetes, Overweight","enrollment":300},{"nctId":"NCT05363592","phase":"PHASE1","title":"A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers","status":"COMPLETED","sponsor":"Celltrion","startDate":"2022-06-25","conditions":"Healthy","enrollment":48},{"nctId":"NCT05363384","phase":"PHASE1","title":"A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers","status":"COMPLETED","sponsor":"Celltrion","startDate":"2022-06-11","conditions":"Healthy","enrollment":48},{"nctId":"NCT03714594","phase":"PHASE2","title":"Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.","status":"COMPLETED","sponsor":"University of Pisa","startDate":"2018-07-24","conditions":"Type2 Diabetes Mellitus","enrollment":48},{"nctId":"NCT05236530","phase":"PHASE1","title":"Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-03-09","conditions":"Malaria","enrollment":48},{"nctId":"NCT01760447","phase":"PHASE3","title":"A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-12-07","conditions":"Type 2 Diabetes Mellitus","enrollment":223},{"nctId":"NCT03898037","phase":"NA","title":"Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome, A Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"Reproductive & Genetic Hospital of CITIC-Xiangya","startDate":"2019-06-13","conditions":"Infertility, Female, Obesity, Insulin Resistance","enrollment":80},{"nctId":"NCT04428086","phase":"PHASE1","title":"A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2020-07-27","conditions":"Solid Tumor, Adult","enrollment":19},{"nctId":"NCT05076877","phase":"PHASE1","title":"A Study of Lazertinib (JNJ-73841937) in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-17","conditions":"Healthy","enrollment":20},{"nctId":"NCT05418452","phase":"PHASE3","title":"Efficacy of 1% Metformin Gel Mixed With PRF in Augmenting Narrow Ridge","status":"UNKNOWN","sponsor":"Al-Azhar University","startDate":"2022-06-15","conditions":"Horizontal Ridge Deficiency","enrollment":2},{"nctId":"NCT04047537","phase":"NA","title":"Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes","status":"TERMINATED","sponsor":"Pendulum Therapeutics","startDate":"2019-08-06","conditions":"Type 2 Diabetes Mellitus","enrollment":41}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"or Metformin HCl alone","genericName":"or Metformin HCl alone","companyName":"Bristol-Myers Squibb","companyId":"bristol-myers-squibb","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin HCl reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in patients with type 2 diabetes. Used for Type 2 diabetes mellitus, Prediabetes (off-label or prevention studies), Polycystic ovary syndrome (PCOS) with insulin resistance.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}